Activist 13D/13G Filings - Ugwumba Chidozie

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-10-02
3:56 pm
Sale		13GClene Inc.
CLNN		Ugwumba Chidozie2,249,661
19.900%		-25,769,247decrease
(-91.97%)		View
2023-12-13
5:20 pm
Sale		13GFINCH THERAPEUTICS GROUP INC C
FNCH		Ugwumba Chidozie160,366
9.990%		-3,339,634decrease
(-95.42%)		View
2023-09-08
6:47 pm
Purchase		13GClene Inc.
CLNN		Ugwumba Chidozie28,018,908
19.900%		22,500,000increase
(+407.69%)		View
2023-02-13
4:08 pm
Purchase		13DClene Inc.
CLNN		Ugwumba Chidozie5,518,908
7.470%		902,054increase
(+19.54%)		View
2023-02-13
3:57 pm
Sale		13GBIOMX INC
PHGE		Ugwumba Chidozie922,800
3.070%		-2,074,225decrease
(-69.21%)		View
2022-11-14
5:10 pm
Sale		13GBIOMX INC
PHGE		Ugwumba Chidozie2,997,025
9.990%		-2,515,821decrease
(-45.64%)		View
2022-05-09
5:37 pm
Purchase		13GSURROZEN INC
SRZN		Ugwumba Chidozie1,964,082
5.500%		1,964,082increase
(New Position)		View
2022-02-14
3:49 pm
Purchase		13GBIOMX INC
PHGE		Ugwumba Chidozie5,512,846
19.280%		5,512,846increase
(New Position)		View
2022-02-14
3:48 pm
Purchase		13GTENAYA THERAPEUTICS INC
TNYA		Ugwumba Chidozie2,642,285
6.400%		2,642,285increase
(New Position)		View
2022-02-14
3:46 pm
Purchase		13GFINCH THERAPEUTICS GROUP INC C
FNCH		Ugwumba Chidozie3,500,000
7.370%		3,500,000increase
(New Position)		View
2022-02-14
3:45 pm
Purchase		13DClene Inc.
CLNN		Ugwumba Chidozie4,616,854
7.420%		4,616,854increase
(New Position)		View